Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
230.84
+0.42 (0.18%)
Dec 11, 2025, 2:39 PM EST - Market open

Danaher Revenue

Danaher had revenue of $6.05B in the quarter ending September 26, 2025, with 4.40% growth. This brings the company's revenue in the last twelve months to $24.27B, up 2.22% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.

Revenue (ttm)
$24.27B
Revenue Growth
+2.22%
P/S Ratio
6.80
Revenue / Employee
$385,206
Employees
63,000
Market Cap
163.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202423.88B-15.00M-0.06%
Dec 31, 202323.89B-2.75B-10.33%
Dec 31, 202226.64B1.84B7.42%
Dec 31, 202124.80B2.52B11.30%
Dec 31, 202022.28B4.37B24.42%
Dec 31, 201917.91B862.00M5.06%
Dec 31, 201817.05B1.53B9.86%
Dec 31, 201715.52B-1.36B-8.08%
Dec 31, 201616.88B2.45B16.97%
Dec 31, 201514.43B1.57B12.18%
Dec 31, 201412.87B-5.42B-29.62%
Dec 31, 201318.28B22.70M0.12%
Dec 31, 201218.26B2.17B13.49%
Dec 31, 201116.09B3.54B28.21%
Dec 31, 201012.55B2.03B19.33%
Dec 31, 200910.52B-2.18B-17.17%
Dec 31, 200812.70B1.67B15.16%
Dec 31, 200711.03B1.56B16.48%
Dec 31, 20069.47B1.59B20.26%
Dec 31, 20057.87B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings